| Nasdaq: ALKS
Alkermes Plc is engaged in the development, manufacture and distribution of medicines. Its products address the following diseases: Multiple Sclerosis Complication, Opioid and Alcohol Dependence, Schizophrenia, Bipolar Disorder and Type 2 Diabetes. Some of its medicine brands are Risperdal, Consta, Invega, Sustenna, Xeplion, Ampyra, Fampyra, Bydureon, Vivitrol, Tricor, Lipanthyl, Lipidil, Supralip, Zanaflex, Avinza, and Emend. The company was founded on September 16, 2011 and is headquartered in Dublin, Ireland.